Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
about
Management standards for stable coronary artery disease in India.Management Protocols of stable coronary artery disease in India: Executive summary.Management of patients with drug-induced atrioventricular block.Third degree atrioventricular block associated with treatment with rivastigmine transdermal patchThe impact of drug discontinuation in patients treated with temporary pacemaker due to atrioventricular block.Atrioventricular dissociation after electroconvulsive therapy.Hypertension management: the primary care nursing role.Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.Management and outcome of topical beta-blocker-induced atrioventricular block.Identifying QT prolongation from ECG impressions using a general-purpose Natural Language Processor.Prognosis and natural history of drug-related bradycardia.Beta-blocker use and risk of symptomatic bradyarrhythmias: a hospital-based case-control study.In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.Management of postoperative atrial fibrillation.The patient journey from symptom onset to pacemaker implantation.Complete heart block in a patient with POEMS syndrome: A case report.Diltiazem: a reversible cause of atrioventricular block - until proven otherwise.Atrioventricular block as a presenting finding of silent right coronary artery disease: treatment by percutaneous coronary intervention.
P2860
Q30239853-A88C1449-497F-43B0-B018-04D355F6B11AQ30240155-30126494-4E98-4DA3-B437-0EC098B34F0EQ33161240-E5F7A223-A29F-420B-A6C6-7017E0B54FDBQ33162691-372EF6D6-6F17-4924-89C0-D89D1A0EA042Q33163054-A4A39740-FBF9-40AD-814D-436E489AD7EEQ35215371-49BF435B-CA2F-4932-9176-7934527E5E2DQ36095733-17722980-469E-4213-A123-31F2AF9A37D4Q36253048-46A70E8E-E032-42D7-8C10-421E95A48A4BQ36656910-91D0F188-B297-4D69-AC3F-D9925E4F2CDFQ37304474-20F2DF25-ADEE-458E-9ADE-7A53C6BA1895Q37408756-08B68A16-08DD-4EEF-A351-1AD5B89AB2A1Q37437851-2D0B3782-74F8-4F88-9EB6-019D8AC75623Q37624888-8836D8B4-B6C9-4514-A04C-2465CFAA6D87Q37978469-3CD12B8A-C42D-4974-8E2A-699FB3F92D32Q38572186-FA9A5727-B8A1-47D9-8519-2FE2867B9101Q42008412-BD548BB5-E805-4924-A2A1-AAB29582E445Q43085891-F14AA6C4-E350-4B15-923B-999FBB85F365Q44326910-AABF43AF-1750-4F94-887E-DD4535371A36
P2860
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@ast
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@en
type
label
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@ast
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@en
prefLabel
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@ast
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
@en
P2093
P1476
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug
@en
P2093
Amir Halkin
David Zeltser
Mordechai Hochenberg
Raphael Rosso
Sami Viskin
P304
P356
10.1016/J.JACC.2004.03.057
P407
P577
2004-07-01T00:00:00Z